DRI Healthcare Trust (TSE:DHT.UN) Price Target Increased to C$22.00 by Analysts at National Bankshares

DRI Healthcare Trust (TSE:DHT.UNFree Report) had its price target upped by National Bankshares from C$18.50 to C$22.00 in a research note released on Friday, BayStreet.CA reports. National Bankshares currently has an outperform rating on the stock.

Other equities analysts also recently issued research reports about the stock. Scotiabank raised their target price on shares of DRI Healthcare Trust from C$22.00 to C$24.00 and gave the company an outperform rating in a research note on Friday. Royal Bank of Canada reissued an outperform rating and issued a C$18.00 target price on shares of DRI Healthcare Trust in a research note on Tuesday, November 28th. CIBC raised their target price on shares of DRI Healthcare Trust from C$18.00 to C$19.00 and gave the company an outperform rating in a research note on Friday. Stifel Nicolaus raised their target price on shares of DRI Healthcare Trust from C$20.00 to C$21.00 and gave the company a buy rating in a research note on Friday. Finally, Raymond James boosted their price objective on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an outperform rating in a report on Friday. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of Buy and an average price target of C$21.00.

View Our Latest Research Report on DHT.UN

DRI Healthcare Trust Trading Up 35.9 %

TSE:DHT.UN opened at C$13.92 on Friday. The stock’s 50 day moving average is C$12.79. DRI Healthcare Trust has a fifty-two week low of C$7.07 and a fifty-two week high of C$14.45.

DRI Healthcare Trust Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 19th. Stockholders of record on Friday, January 19th were given a $0.075 dividend. This represents a $0.30 annualized dividend and a dividend yield of 2.16%. The ex-dividend date was Thursday, December 28th. DRI Healthcare Trust’s payout ratio is currently 18.52%.

About DRI Healthcare Trust

(Get Free Report)

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Further Reading

Analyst Recommendations for DRI Healthcare Trust (TSE:DHT.UN)

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.